Fear of repeated injections in children younger than 4 years receiving subcutaneous allergy immunotherapy.

CONCLUSION: Our analysis suggests that most children receiving weekly subcutaneous immunotherapy lose their fear of injections during the treatment course. Children with increased intervals between visits may be at higher risk of experiencing fear of injections. CLINICAL TRIAL REGISTRATION: clinicaltrial.gov identifier NCT01028560. PMID: 23176889 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/PubMed/23176889?dopt=Abstract

Source: Annals of Allergy, Asthma and Immunology - December 1, 2012 Category: Allergy & Immunology Authors: de Vos G, Shankar V, Nazari R, Kooragayalu S, Smith M, Wiznia A, Rosenstreich D Tags: Ann Allergy Asthma Immunol Source Type: research